Capital Surplus、Increase In Property Plant And Equipment And Intangible Assets - Medicine Reportable Segments Member、Provision For Sales Returns他1件
- 【期間】
| 年度 | Capital Surplus | Increase In Property Plant And Equipment And Intangible Assets - Medicine Reportable Segments Member | Provision For Sales Returns | その他の包括利益合計 |
|---|
| 2010/09 | - | | - | | - | | -4.29億 | |
| 2011/09 | - | | - | | - | | -0.71億 | 赤縮 |
| 2012/09 | - | | - | | - | | -1.88億 | 赤拡 |
| 2013/09 | - | | - | | - | | 1.03億 | 黒転 |
| 2014/09 | - | | - | | - | | 9.64億 | +835.9% |
| 2015/09 | - | | - | | - | | -11.8億 | 赤転 |
| 2016/09 | - | | - | | - | | 1.5億 | 黒転 |
| 2017/09 | - | | - | | - | | 13.9億 | +823.3% |
| 2018/09 | - | | - | | - | | 10.1億 | -27.2% |
| 2019/09 | - | | - | | - | | -2.68億 | 赤転 |
| 2020/09 | - | | - | | - | | 9.09億 | 黒転 |
| 2021/09 | - | | - | | - | | 5.85億 | -35.6% |
| 2022/09 | - | | - | | - | | 2.45億 | -58.1% |
| 2023/09 | - | | - | | - | | 17.5億 | +612.2% |
| 2024/09 | - | | - | | - | | -8.16億 | 赤転 |
